| Company Name: |
Shanghai YuanYe Biotechnology Co., Ltd.
|
| Tel: |
021-61312847; 18021002903 |
| Email: |
3008007409@qq.com |
| Products Intro: |
Product Name:Labetuzumab (anti-CEACAM5)
CAS:219649-07-7
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:100μg Remarks:K13660
|
| Company Name: |
ShangHai Biochempartner Co.,Ltd
|
| Tel: |
177-54423994 17754423994 |
| Email: |
2853530910@QQ.com |
| Products Intro: |
Product Name:Labetuzumab
CAS:219649-07-7
Purity:95% Package:100ug;500ug;1mg
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:Labetuzumab
CAS:219649-07-7
Package:1mg/RMB 2980;5mg/RMB 6970;10mg/RMB 9390
|
Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer manufacturers
- Labetuzumab
-
- $347.00 / 1mg
-
2026-04-20
- CAS:219649-07-7
- Min. Order:
- Purity: 95.2% (SDS-PAGE); 95.6% (SEC-HPLC)
- Supply Ability: 10g
|
| | Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer Basic information |
| | Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer Usage And Synthesis |
| Uses | Treatment of colorectal cancer (humanized monoclonal antibody hMN-14 targeting CEA-
positive cancers). | | Brand name | CEA-CIDE (Immunomedics). | | in vivo | Labetuzumab (0.5 mg/rat; i.v.; single) inhibits tumor growth in vivo[1]. | Animal Model: | Female nu/nu mice (6 to 8-week-old; inject TT cells)[1]. | | Dosage: | 0.5 mg/rat | | Administration: | Intravenous injection; single (1 day post-tumor cell injection) | | Result: | Significantly delaied growth of tumor, and led to 64%-70% inhibition of tumor size between days 32 and 60. |
|
| | Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer Preparation Products And Raw materials |
|